|
|
Post by mnholdem on Oct 24, 2014 9:01:00 GMT -5
All valid points. I just wonder if longs can manipulate stock UP using the same tactics as shorts do in the opposite direction. Perhaps with such low volume it's pointless to speculate anyway. I'm merely expressing surprise that pps is rising on low volume. That certainly has not been the case for the past couple of months.
|
|
|
|
Post by goyocafe on Oct 24, 2014 9:27:18 GMT -5
All valid points. I just wonder if longs can manipulate stock UP using the same tactics as shorts do in the opposite direction. Perhaps with such low volume it's pointless to speculate anyway. I'm merely expressing surprise that pps is rising on low volume. That certainly has not been the case for the past couple of months. If there was an antithesis to the stop loss you might be on to something. |
|
|
|
Post by babaoriley on Oct 24, 2014 11:01:53 GMT -5
Spiro, your football analogy has my head spinning! In fact, your entire post does! Still, I believe you are correct, as always.
mnholdem, absolutely a stock can be manipulated upwards. I've been in a few stocks like that (way too few, by the way), and longs never want to believe its manipulation that got the price where it got, but those things, like Ponzi schemes always end badly, you just need to be out of there, before the fall, cuz it's usually precipitous.
|
|
|
|
Post by mnholdem on Oct 24, 2014 14:11:17 GMT -5
Short interest report is today after hours, plus the Sanofi earnings call next Tuesday. Hmmmm...
|
|
|
|
Post by mnholdem on Oct 24, 2014 14:20:09 GMT -5
Ok, because you guys seem to be struggling on this thread, Spiro has decided to help out. With MNKD, No news is good news. good news is bad news. I don't know about you guys, but my portfolio can't handle any explosive good news from MNKD. Spiro says it's like a football game, where one team is so much better than it's opponents, that their bungling management can fumble the ball 10 times and still win the game. But as long as the team wins, it's unlikely that the coaches will lose their jobs. It's obvious that Sanofi got a couple of pick 6's from MNKD, in addition to 10 fumbles. We just need to hope that MNKD has enough left to win the game. I hope this helps, Spiro A little uzo ought to help me figure out what you just wrote. The fumbles I get, but Sanofi/Mannkind are on the same team. Speaking of pick 6's, though, here in Minnesota we just commemorated Jim Marshall's infamous interception, where lost his sense of direction after getting spun around and then he ran it into the wrong endzone. Would that be a reverse pick-6?
Back on track... I'm glad to hear Matt say that MannKind is getting help with their drug pipeline from a "big" pharmaceutical company. All the fumbles during the FDA trials dramatically illustrated how inexperienced MNKD management was. Now, who could that company be that will help MannKind develop its drug "portfolio" I wonder?
|
|
|
|
Post by jpg on Oct 24, 2014 15:08:29 GMT -5
Back on track... I'm glad to hear Matt say that MannKind is getting help with their drug pipeline from a "big" pharmaceutical company. All the fumbles during the FDA trials dramatically illustrated how inexperienced MNKD management was. Now, who could that company be that will help MannKind develop its drug "portfolio" I wonder?
Hi MNHoldem, Matt said 'that MannKind is getting help with their drug pipeline from a "big" pharmaceutical company'. When and in what context? Thank you, JPG |
|
|
|
Post by brentie on Oct 24, 2014 15:15:01 GMT -5
Back on track... I'm glad to hear Matt say that MannKind is getting help with their drug pipeline from a "big" pharmaceutical company. All the fumbles during the FDA trials dramatically illustrated how inexperienced MNKD management was. Now, who could that company be that will help MannKind develop its drug "portfolio" I wonder?
Hi MNHoldem, Matt said 'that MannKind is getting help with their drug pipeline from a "big" pharmaceutical company'. When and in what context? Thank you, JPG This is what Hakan said: Unidentified Analyst We’ll be digging into that a little bit. Can you discuss broadly your plans for future R&D initiatives and applications for your inhalation technologies? Hakan Edstrom - President and COO Actually, we are right now in discussions with one of the major companies looking into kind of portfolio management. We want to make sure that beyond what we understand ourselves, our technology can accomplish that we look at significant unmet medical needs and we look at what are good business opportunities. So, we are just in the process of launching that and we’ll have a discussion with our board in November and in February in regards to the areas that we think are our significant investment opportunities. We’ve done that is already in GLP-1 for instance with our product and we did see some very good effects there and actions in that scenario where Sanofi even has an access to and if they want to. Pain management is another area where we’ve seen our PK/PD profile make a significant difference for instance for people that are suffering from migraine and other ad hoc opportunities where also you are not looking at the chronic use of the products for inhalation, it really becomes much less of an issue. So I would say in the next couple of quarters, we will be able to come back and elaborate even further in terms of what specific technologies that we are or disease areas that we will hopefully approach with our technologies. seekingalpha.com/article/2482785-mannkinds-management-presents-at-morgan-stanley-global-healthcare-conference-transcript?find=major&all=false |
|
|
|
Post by EveningOfTheDay on Oct 24, 2014 16:08:36 GMT -5
Thanks for reminding us about that deal, way back in 2009. I was really surprised when I went back and read the article again that the Sanofi spokesman said about the deal, "We hope that by frustrating MannKind's bid at this time, we put ourselves in a better position to partner with them once they get FDA approval, assuming MannKind finally stops fumbling the ball near the goal line with the FDA. Once we partner with them, it will only be a matter of time before we buy them out - their shareholders won't know what hit them." Again, surprising, wouldn't you say? Aloha Babaoriley, i have never seen that quote before. Was that really what the Sanofi guy said? Or I am salivating for no good reason. I understand, that was a few years ago and things could have changed, but we actually parter up with Sanofi, and they seem to be somewhat in control of the situation now. Basically, there is no indication of when or if they will ever acquire Mannkind, but there is no real reason to assume they have changed their minds either. Actually, quite the opposite. Would you post the original article? Thanks. |
|
|
|
Post by EveningOfTheDay on Oct 24, 2014 16:12:33 GMT -5
Ok, because you guys seem to be struggling on this thread, Spiro has decided to help out. With MNKD, No news is good news. good news is bad news. I don't know about you guys, but my portfolio can't handle any explosive good news from MNKD. Spiro says it's like a football game, where one team is so much better than it's opponents, that their bungling management can fumble the ball 10 times and still win the game. But as long as the team wins, it's unlikely that the coaches will lose their jobs. It's obvious that Sanofi got a couple of pick 6's from MNKD, in addition to 10 fumbles. We just need to hope that MNKD has enough left to win the game. I hope this helps, Spiro Spiro, does that analogy translate into the the other football, a.k.a soccer? Sorry mate, you have a wimpy european here. Well, at least, for what I read, I am not the only one scratching my head. Cheers and good weekend to all. |
|
|
|
Post by liane on Oct 24, 2014 16:19:26 GMT -5
Thanks for reminding us about that deal, way back in 2009. I was really surprised when I went back and read the article again that the Sanofi spokesman said about the deal, "We hope that by frustrating MannKind's bid at this time, we put ourselves in a better position to partner with them once they get FDA approval, assuming MannKind finally stops fumbling the ball near the goal line with the FDA. Once we partner with them, it will only be a matter of time before we buy them out - their shareholders won't know what hit them." Again, surprising, wouldn't you say? Aloha Babaoriley, i have never seen that quote before. Was that really what the Sanofi guy said? Or I am salivating for no good reason. I understand, that was a few years ago and things could have changed, but we actually parter up with Sanofi, and they seem to be somewhat in control of the situation now. Basically, there is no indication of when or if they will ever acquire Mannkind, but there is no real reason to assume they have changed their minds either. Actually, quite the opposite. Would you post the original article? Thanks. EOD, I may be wrong, but I do believe that is just baba messing with our heads. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 24, 2014 16:23:26 GMT -5
I took Hakans comment to mean they were working with an asset management company, not necessarily BP.
They are probably sitting down with some expert, showing them their pipeline and letting said expert tell them "this is your best option(s)".
Again though I didn't read it to mean BP
|
|
|
|
Post by EveningOfTheDay on Oct 24, 2014 16:25:18 GMT -5
Aloha Babaoriley, i have never seen that quote before. Was that really what the Sanofi guy said? Or I am salivating for no good reason. I understand, that was a few years ago and things could have changed, but we actually parter up with Sanofi, and they seem to be somewhat in control of the situation now. Basically, there is no indication of when or if they will ever acquire Mannkind, but there is no real reason to assume they have changed their minds either. Actually, quite the opposite. Would you post the original article? Thanks. EOD, I may be wrong, but I do believe that is just baba messing with our heads. i suspected as much, but heck, i thought I might ask anyway. |
|
